Pre-Lac

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pre-Lac

What is Pre-Lac?

Pre-Lac is a therapeutic formulation containing lactulose, a synthetic derivative of lactose. It belongs to a class of medications known as osmotic laxatives. Unlike many other substances, lactulose is not absorbed into the bloodstream; instead, it passes through the upper digestive tract unchanged until it reaches the colon.

Mechanism of Action

In the large intestine, Pre-Lac undergoes a metabolic process where it is broken down by resident colonic bacteria into low-molecular-weight organic acids, such as lactic acid and acetic acid. This process serves two primary functions:

  • Osmotic Effect: The accumulation of these organic acids increases the osmotic pressure within the bowel. This draws water into the intestinal lumen, softening the stool and increasing its volume, which naturally stimulates intestinal movement (peristalsis).
  • Ammonia Reduction: The acidification of the colonic contents converts ammonia (NH3) into ammonium ions (NH4^+). Because ammonium ions are charged, they cannot be easily reabsorbed into the blood. This effectively traps ammonia in the gut, allowing it to be excreted from the body.

Clinical Applications

Pre-Lac is primarily utilized in clinical settings for two distinct purposes:

  1. Constipation Management: It is used to provide relief for chronic or occasional constipation by facilitating regular bowel movements through its water-retaining properties.
  2. Hepatic Encephalopathy: It is used as a supportive treatment for portal-systemic encephalopathy, a condition where brain function is affected by high levels of toxins in the blood. By reducing the absorption of ammonia from the gut, Pre-Lac helps lower systemic ammonia levels.

Regulatory References

  1. Folate - Health Professional Fact Sheet
  2. Folic Acid: MedlinePlus Drug Information

What side effects are possible with Pre-Lac?

The safety profile of Pre-Lac (Folic Acid) is defined by official regulatory documents, which categorize potential adverse reactions based on system organ classes and frequency of occurrence.

Regulatory Classification of Adverse Reactions

Adverse reactions associated with Folic Acid are generally categorized as Rare or of Not known frequency (cannot be estimated from available data) in official labeling. Reactions are grouped by the affected system:

  • Immune System Disorders: These include the most serious potential reactions, such as anaphylaxis, angioedema, and bronchospasm, which are classified as rare events.
  • Skin and Subcutaneous Tissue Disorders: Reported effects include rash, pruritus (itching), erythema, and urticaria (hives).
  • Gastrointestinal Disorders: Effects such as nausea, abdominal distention, and flatulence have been noted.
  • General and Psychiatric Disorders: Malaise, hyperthermia, irritability, and altered sleep patterns are also documented in regulatory safety data.

Safety Constraints and Considerations

A critical regulatory constraint involves its use in individuals with untreated pernicious anemia or other B12 deficiencies. Folic Acid must not be used alone in these cases as it can mask the hematological signs of anemia while allowing the associated neurological damage to continue progressing. Official documentation also advises caution for use in individuals with malignant disease and notes specific considerations for patients undergoing renal dialysis.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Pre-Lac (Folic Acid) overdose indicates that the substance is generally considered to have low acute toxicity in humans. Consequently, no specific antidote is known for acute overdose.

Documented Manifestations and Actions

Overdose manifestations, particularly following chronic ingestion of very high doses, are typically mild and non-specific, centered on gastrointestinal disturbances such as nausea, abdominal distension, and flatulence. Minor effects on the central nervous system, such as altered sleep patterns and irritability, have also been reported.

Treatment is predominantly symptomatic and supportive, and requires the discontinuation of the medicine. Hospital observation and monitoring may be required in cases of massive ingestion.

Regulatory Requirements for Seeking Medical Help

Immediate medical attention must be sought for any suspected severe overdose or for the occurrence of signs of a serious allergic reaction (anaphylaxis), such as sudden swelling, difficulty breathing, or wheezing. Additionally, official labeling notes that high-dose folic acid may critically mask the hematologic signs of undiagnosed Vitamin B12 deficiency (Pernicious Anemia), which allows severe neurological damage to progress unnoticed.

Therapeutic Uses of Pre-Lac

What Pre-Lac Treats: Main Uses and Benefits

Pre-Lac is commonly used to help with symptoms that interfere with daily functioning, specifically those associated with megaloblastic and other macrocytic anemias caused by a lack of Folic Acid. The medicine contributes to easing systemic symptoms like profound fatigue, persistent weakness, and the pallor of anemia, as well as deficiency-related oral discomfort like a sore tongue (glossitis). This supports the patient during difficult episodes by easing the symptoms that interfere with daily functioning, contributing to improved comfort. The medicine is commonly used across conditions presenting with systemic imbalance associated with folate deficiency anemia. This supports the body during difficult episodes by easing symptoms that create noticeable physiological strain.

Supportive Nutritional Management and Prophylaxis

The medicine is considered relevant for individuals planning or undergoing pregnancy, particularly during the periconceptional period. This use may be part of symptomatic management by providing nutritional support that contributes to improved development, and may assist with reducing the risk of Neural Tube Defects (NTDs). Pre-Lac is also applied in addressing deficiency states secondary to malabsorption syndromes or chronic diseases with heightened physiological activity. This therapeutic focus is relevant for easing symptoms that interfere with functional stability, which helps maintain a sense of stability when symptoms are more noticeable. The medicine is used to support these nutritional and symptomatic needs.


“This supplement is generally used in areas where nutritional support is needed to address anemia symptoms and to assist with reducing specific developmental risks.”


Quick Fact

Quick Fact: Supports managing symptoms related to Systemic Imbalance

Eligibility and Restrictions for Use

Who Can and Cannot Use Pre-Lac? (Folic Acid Preparation)

This section details the official population eligibility and non-eligibility rules for Pre-Lac (Folic Acid), based strictly on governmental regulatory documents.


Official Contraindications and Restrictions

Category Regulatory Status
Hypersensitivity Contraindicated in individuals with known allergy to Folic Acid or any component of the formulation.
Untreated B12 Deficiency Contraindicated. Must not be used as sole therapy for untreated pernicious anemia or other undiagnosed Vitamin B12 deficiency states, as Folic Acid can mask the condition.
Undiagnosed Anemia Not Recommended. Use is restricted until a definitive diagnosis confirms the type of anemia.

Age and Life Stage Eligibility

Population Group Eligibility Status
Pregnant Women Established Use. Specifically indicated for the prophylaxis of Neural Tube Defects (NTDs) and for the treatment of deficiency.
Breastfeeding Women Established Use. Compatible with breastfeeding.
Children (Pediatric) Approved for Use. Eligibility is generally established, with dosing based on age and weight.
Older Adults (Geriatric) Approved for Use. No blanket restriction is documented.

Use of Pre-Lac is generally established for patients with documented folate deficiency, provided they meet the diagnostic requirements. The medicine is contraindicated only by the two critical exclusions: hypersensitivity and the presence of an untreated Vitamin B12 deficiency.

What should I know about interactions with other medicines?

The documented interaction profile for Pre-Lac (Folic Acid) is defined by its effects on the plasma concentration of co-administered medicines and by agents that interfere with its own absorption. Co-administration with anticonvulsants such as phenytoin, primidone, and phenobarbital is documented to result in a reduction in the serum concentration of these medicines. This pharmacokinetic outcome requires specific caution for epileptic patients due to the potential risk of increased seizure susceptibility, as explicitly noted in regulatory documents.

A pharmacodynamic antagonism is documented with antifolate agents like methotrexate and trimethoprim. Folic acid may interfere with the therapeutic effects of these drugs due to competing metabolic pathways. Similarly, the antibiotic Chloramphenicol may hinder the haematopoietic response to Folic Acid treatment.

Several other agents, including Sulfasalazine and certain antacids, are documented to reduce the absorption of Folic Acid. To mitigate this absorption interference, regulatory documents establish mandatory timing requirements:

  • Cholestyramine: Must be separated from Folic Acid by at least one hour before or four to six hours after.
  • Antacids: Must be taken at least two hours after Folic Acid administration.

Chronic alcohol consumption is also documented to reduce Folic Acid absorption and increase its elimination. Furthermore, long-term Folic Acid therapy is restricted in any patient with untreated cobalamin (Vitamin B12) deficiency to avoid masking the deficiency's hematological symptoms while allowing neurological progression.

Mechanism of Action

How Pre-Lac Works


The synthetic Folic Acid in Pre-Lac acts as an inactive precursor that must be enzymatically reduced by Dihydrofolate Reductase (DHFR) into its biologically functional form, Tetrahydrofolate (THF). THF and its derivatives function as essential cofactors capable of carrying and donating single carbon ( C1) units required for key biosynthetic reactions. This mechanism is central to the One-Carbon Metabolism Pathway, where active folate cofactors serve as indispensable C1 donors to create new purine bases and the pyrimidine base Thymidylate (dTMP).

By ensuring these building blocks are available, the mechanism enables the necessary DNA replication and completion of mitosis (cell division) in rapidly proliferating cells. The physiological consequence of supported DNA synthesis is most evident in the haematopoietic system. By sustaining cell division, the mechanism facilitates the necessary proliferation and maturation of erythrocyte precursor cells in the bone marrow, resulting in the formation of red blood cell precursors with maintained molecular integrity. Furthermore, a key step involves the Methionine Synthase (MTR) enzyme, which facilitates the remethylation of Homocysteine back into Methionine, a reaction that is obligately dependent on Vitamin B12 (Cobalamin).

Dosage and Administration Information

How to Use Pre-Lac (Folic Acid)

The usage of Pre-Lac is determined by standardized guidelines, defining the appropriate route, dose, and frequency for administration. The primary route is oral administration, typically using tablets or capsules, though parenteral (Intravenous, Intramuscular, or Subcutaneous) injection is an alternative for individuals with severe malabsorption or when oral intake is not feasible.

Official Dosing and Schedule

Usage Context Standard Adult Dose and Frequency
Treatment of Deficiency Typically 1 mg daily, with guidelines allowing up to 5 mg daily for severe or malabsorptive states.
High-Risk Prophylaxis A specific regimen of 4 mg to 5 mg daily is prescribed, such as for periconceptional support.

The standard frequency for Folic Acid is once daily (OD) for both therapeutic and maintenance regimens. For most oral formulations, the medication may be taken with or without food, providing flexibility in the administration schedule.

Administration and Procedural Rules

Use for specific populations involves adjustments, such as tailored doses for pediatric patients (starting around 0.1 mg daily for infants) and specific maintenance requirements for pregnancy. If a dose is missed, instructions advise taking it as soon as it is remembered, unless it is almost time for the next scheduled dose, in which case the user should simply skip the missed dose. The course duration is typically short-term (e.g., four months) for correcting acute deficiency but may be required long-term or indefinitely for chronic conditions.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pre-Lac


Evidence for use in relating to Outcomes Related to Physical Discomfort

Pre-Lac was studied for its association with outcomes related to physical discomfort. Research examined how the use of Pre-Lac was observed in studies monitoring symptom intensity or variability in the digestive tract. These studies often involved individuals experiencing conditions characterized by fluctuating or episodic manifestations.

The findings describe patterns observed in the studies where participants reported perceived discomfort over defined time intervals. Research has primarily focused on short-term symptom changes and how frequently individuals reported temporary discomfort.

While some studies suggest patterns related to outcomes reflecting daily functioning or activity level, long-term effects are not fully established, and certainty remains low due to the nature of the available data.


Evidence for use in regularity and healthy bowel movement patterns

Research explored patterns related to regularity and healthy bowel movement patterns and these were evaluated in various research settings. These studies focused on outcomes related to functional imbalance and tracking the consistency and frequency of bowel movements. Studies explored findings in populations where outcomes reflecting daily functioning or activity level were reported.

Some data show patterns related to conditions where symptoms may vary in intensity. However, findings were mixed across different research settings, meaning not every study reported the same observations.

Follow-up durations were limited in many of these studies, meaning there is limited information for long-term outcomes.


Long-term studies and follow-up

This section summarizes what is known and what is still uncertain about the long-term outcomes of Pre-Lac. The available research describes patient-reported experiences monitored during the study period, focusing primarily on short-term responses. Because follow-up durations were limited in many trials, data are still emerging regarding the durability of any observed changes. There is limited information for long-term outcomes, and understanding them is an area where research is ongoing.


What is still uncertain about Pre-Lac

The current body of research provides context, but it also highlights several areas where more evidence is needed. First, the research landscape includes studies where evidence quality varies, and in some areas, comparative evidence is lacking. Research provides context but not individual predictions. Further studies are needed to address these limitations and provide greater certainty.

Frequently Asked Questions (FAQ)

Common questions about Pre-Lac (FAQ)


Q: How quickly does Pre-Lac typically start working?

A: Folic acid is reported in official documents to appear in the plasma (blood) in approximately 15 to 30 minutes after an oral dose, with peak levels typically reached within one hour. This is how quickly the medicine enters the body. The time it takes to observe a therapeutic outcome related to a specific condition may be longer.

Q: What is the biggest difference between Pre-Lac and other medicines for the same condition?

A: Official information indicates that Pre-Lac contains Folic Acid, which is the stable, synthetic form of the B9 vitamin. This synthetic form is described as offering superior chemical stability and predictable bioavailability compared to natural folates found in foods.

Q: Are there any foods or drinks to avoid while taking Pre-Lac?

A: Regulatory documents state that the medication may be taken with or without food, allowing flexibility in its use. However, specific instructions advise separating it from certain products, such as antacids or Cholestyramine, by at least two hours to prevent absorption interference. Chronic alcohol consumption is also documented to reduce its absorption and increase the speed at which it is cleared from the body.

Q: Does Pre-Lac interact with birth control pills?

A: Regulatory literature has noted that oral contraceptive pills may cause a decrease in the body’s folate levels. Official literature notes that monitoring of folate status may be warranted during co-administration due to this potential effect.

Q: Can people who are lactose intolerant use Pre-Lac?

A: According to the official product information, the inactive ingredients used in many standard oral tablet formulations of Folic Acid often include lactose monohydrate. The presence of this ingredient is noted for individuals with known hypersensitivity or intolerance to lactose.

Q: What other medicines or conditions are important to mention to a doctor before starting Pre-Lac?

A: Official documents highlight several conditions and medications requiring careful consideration before use. These include: having an untreated Vitamin B12 deficiency, having malignant disease, undergoing renal dialysis, or taking antifolate medicines like methotrexate or specific anticonvulsants (e.g., phenytoin).

Q: Can I use Pre-Lac if I have kidney issues?

A: Regulatory information addresses the use of Folic Acid in patients undergoing renal dialysis, noting that folate levels may be depleted and the dose may require specific adjustment. The official documents do not list general kidney issues as a direct restriction, but specific considerations are noted for patients undergoing renal dialysis.

Q: Can I cut or crush the Pre-Lac tablets?

A: Official product information sometimes describes Folic Acid tablets as being manufactured with a physical score or 'bisect' line. This physical feature is the regulatory indication that a tablet is designed to be safely divided for administration.

Q: Does alcohol change the effect of Pre-Lac?

A: Official documents state that chronic alcohol consumption is documented to reduce the absorption of Folic Acid. It may also increase the speed at which it is eliminated from the body.

Q: Is Pre-Lac the same ingredient as what is in over-the-counter supplements?

A: The active ingredient in Pre-Lac is Folic Acid, the same component found in many over-the-counter supplements. However, the pharmaceutical preparation is typically available by prescription in higher strengths (e.g., 1 mg or 5 mg), compared to the generally lower microgram strengths commonly available without a prescription.

Q: Is Pre-Lac known to cause weight gain or weight loss?

A: Official regulatory safety documents for Folic Acid do not list weight gain or weight loss among the documented or reported adverse reactions for the medicine.

Q: Is it safe to drive after taking Pre-Lac?

A: The regulatory safety profile documents potential central nervous system (CNS) effects such as altered sleep patterns, malaise, and, at higher doses, confusion. Official information documents these effects and indicates that awareness of how the medicine affects your body is warranted.

Q: Why is Pre-Lac sometimes called by a different name?

A: Like many medicines, Pre-Lac is a brand name for the active ingredient, Folic Acid. This active ingredient is widely available under its official generic name or other brand names, depending on the manufacturer and country.

Q: Does Pre-Lac have a risk of dependence or withdrawal?

A: Official documents regarding the safety and adverse reactions of Folic Acid do not contain information related to dependence, abuse, or withdrawal risk.

Q: What is the typical duration of treatment with Pre-Lac?

A: For correcting acute folate deficiency, the course duration is typically described in official documents as around four months. However, use may be required long-term or indefinitely for chronic underlying conditions.

Q: Are there different versions or strengths of Pre-Lac?

A: Folic Acid is available as a prescription medication in several strengths to meet different therapeutic requirements. Official information documents multiple tablet strengths, including 0.4 mg, 1 mg, and 5 mg.

Q: Is there a generic version of Pre-Lac available?

A: The active ingredient in Pre-Lac, Folic Acid, is widely available in generic form under its official non-proprietary name.

Q: Is there a specific time of day that is best for taking Pre-Lac?

A: Official instructions generally state that the medicine can be taken with or without food, allowing flexibility in the timing of administration. There is no specified 'best' time of day that is mandatory for all patients.

Q: Can Pre-Lac be taken on an empty stomach?

A: Yes, official administration guidelines explicitly state that the medicine may be taken with or without food.

How should Pre-Lac be stored and disposed of?

Storage and Handling Requirements

Pre-Lac (Folic Acid tablets/capsules) must be stored at Controlled Room Temperature, typically 20 C to 25 C. To maintain stability, the medication must be protected from light, moisture, and excess heat, and should never be frozen.

It is mandatory to keep the medication in its original container and ensure the container remains tightly closed. The product must be stored out of the reach of children to comply with safety regulations.

Disposal Instructions

Any unused or expired Pre-Lac must be properly discarded. The recommended method is to use an official drug take-back program. If a take-back program is not available, the medicine may be mixed with an undesirable substance (such as used coffee grounds) and placed in a sealed bag before disposal in the household trash, as specified by regulatory guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pre-Lac found in:

A-Z Index: